Original price was: $8,999.00.$5,999.00Current price is: $5,999.00.
In Stock
Indications for the drug Braftovi
In combination with binimetinib (the target of which is another protein that stimulates the growth of tumor cells) for the treatment of skin cancer (melanoma) in the presence of a mutation in the gene responsible for the production of the BRAF protein, with damage to other organs and systems, or cannot be removed surgically.
In combination with cetuximab (which binds to EGFR) for the treatment of colon cancer with a mutation in the gene responsible for the production of the BRAF protein, with damage to other organs and systems in those patients who have previously been treated with other anticancer drugs.
Active ingredient: encorafinib
Prescription medicine
